Nova Eye Medical Limited (ASX:EYE)
Australia flag Australia · Delayed Price · Currency is AUD
0.1600
0.00 (0.00%)
Nov 17, 2026, 9:59 AM AEDT

Nova Eye Medical Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
463031505027
Market Cap Growth
23.12%-4.30%-37.91%-0.19%87.27%-41.43%
Enterprise Value
473032495016
Last Close Price
0.160.100.110.220.260.18

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-297.83297.83297.83297.83297.83
PS Ratio
1.310.861.072.162.962.01
PB Ratio
3.192.101.652.362.170.89
P/TBV Ratio
5.523.622.583.523.421.16

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
1.350.861.112.102.921.16

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.170.170.160.160.070.06
Net Debt / Equity Ratio
0.100.10-0.11-0.13-0.25-0.20
Net Debt / EBITDA Ratio
-0.42-0.420.260.390.620.77
Net Debt / FCF Ratio
-0.42-0.420.320.350.831.25
Asset Turnover
1.451.451.040.770.510.34
Inventory Turnover
3.253.252.931.610.720.71
Quick Ratio
1.101.101.791.801.683.05
Current Ratio
1.741.742.392.602.334.04
Return on Equity (ROE)
-26.07%-26.07%-44.96%-39.49%-57.08%-22.81%
Return on Assets (ROA)
-11.37%-11.37%-19.92%-18.62%-21.98%-15.42%
Return on Invested Capital (ROIC)
-27.86%-26.81%-50.68%-50.09%-56.57%-42.57%
Return on Capital Employed (ROCE)
-27.20%-27.20%-42.10%-37.10%-48.90%-29.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-9.52%-14.49%-28.98%-17.46%-30.32%-27.83%
FCF Yield
-7.42%-11.31%-20.63%-16.03%-14.05%-18.02%
Buyback Yield / Dilution
-15.03%-15.03%-21.16%-30.89%-7.83%-0.69%